June 28 (Reuters) - Magle Chemoswed Holding AB
MAGLE.ST :
* ENTERS INTO MERGER AGREEMENT REGARDING THE ACQUISITION OF
PK
BIOTECH APS AND PK CHEMICALS A/S
* PURCHASE PRICE FOR ALL SHARES IN PK BIOTECH WILL BE PAID
IN FORM
OF A SELLER PROMISSORY NOTE OF APPROXIMATELY SEK 240 MILLION
* SELLER PROMISSORY NOTE WILL BE OFFSET AGAINST 7,200,000
NEWLY
ISSUED SHARES IN MAGLE GROUP
* MERGER IS EXPECTED TO CREATE VALUE FOR SHAREHOLDERS OF NEW
MAGLE
GROUP THROUGH SYNERGIES
* SYNERGIES SUCH AS NCREASED PRODUCTION CAPACITY, ENHANCED
CDMO
CAPABILITIES AND BROADENED SERVICE OFFERING
* IN TOTAL, VALUE OF SYNERGIES FROM SUCH COST SAVINGS ARE
ESTIMATED TO AMOUNT TO BETWEEN SEK 7 MILLION AND 11 MILLION
ANNUALLY
* SYNERGIES ARE EXPECTED TO BE UNLOCKED WITHIN 12 TO 24
MONTHS
* ACQUISITION IS EXPECTED TO BE COMPLETED IN JULY 2024
Source text for Eikon: ID:nMFN7PnX1P
Further company coverage: MAGLE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))